PCH
REGN icon

Polar Capital Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Polar Capital Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-192,546
Closed -$149M – 265
2026
Q1 		$149M Sell
192,546
-12,381
-6% -$9.48M 0.53% 51
2025
Q4 		$158M Buy
204,927
+46,110
+29% +$31.3M 0.61% 45
2025
Q3 		$89.3M Buy
158,817
+88,817
+127% +$50.2M 0.43% 67
2025
Q2 		$36.8M Buy
70,000
+15,000
+27% +$8.37M 0.19% 104
2025
Q1 		$34.9M Sell
55,000
-1,249
-2% -$859K 0.21% 115
2024
Q4 		$40.1M Sell
56,249
-15,546
-22% -$13M 0.22% 111
2024
Q3 		$75.5M Sell
71,795
-61,236
-46% -$68.1M 0.36% 62
2024
Q2 		$140M Sell
133,031
-43,927
-25% -$42.6M 0.82% 31
2024
Q1 		$170M Sell
176,958
-20,889
-11% -$19.9M 0.89% 26
2023
Q4 		$174M Buy
197,847
+65,347
+49% +$53.8M 1.06% 16
2023
Q3 		$109M Hold
132,500
– – 0.81% 30
2023
Q2 		$95.2M Hold
132,500
– – 0.48% 46
2023
Q1 		$109M Buy
132,500
+15,000
+13% +$11.3M 0.71% 35
2022
Q4 		$84.8M Buy
117,500
+5,000
+4% +$3.69M 0.68% 43
2022
Q3 		$77.5M Sell
112,500
-12,500
-10% -$7.87M 0.49% 51
2022
Q2 		$73.9M Sell
125,000
-20,000
-14% -$13M 0.43% 59
2022
Q1 		$101M Sell
145,000
-25,000
-15% -$15.8M 0.46% 45
2021
Q4 		$107M Hold
170,000
– – 0.4% 49
2021
Q3 		$103M Buy
170,000
+20,000
+13% +$12.4M 0.42% 50
2021
Q2 		$83.8M Buy
150,000
+75,000
+100% +$38M 0.36% 64
2021
Q1 		$35.5M Sell
75,000
-20,000
-21% -$9.74M 0.22% 115
2020
Q4 		$45.9M Buy
+95,000
New +$51.3M 0.28% 101

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Polar Capital Holdings's REGN Position: Q2 2026 in Review

Polar Capital Holdings sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 192,546 shares — an estimated $149M sold.

Polar Capital Holdings first reported a position in REGN in Q4 2020 and held it in 22 quarters. The position peaked at $174M in Q4 2023. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Polar Capital Holdings reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Polar Capital Holdings sold 192,546 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $149M.
  • Polar Capital Holdings first reported a position in Regeneron Pharmaceuticals in Q4 2020 and held it in 22 quarters.
  • Polar Capital Holdings's Regeneron Pharmaceuticals position peaked at $174M in Q4 2023.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.